Also, considering the significant survival differences of subgroup analysis based on FOXP3 and TIL PD-L1, TIL PD-1, TIL LAG-3, CD3, CD4, CD8, or PD-L1 on tumor cells, we established seven unique immune risk scores using multivariate Cox analysis and compared their performance with XGBoost-based risk score. The gene discussed is PDCD1; the disease is neoplasm.